Article

Akreos MICS lens gets the thumbs up

Cataract surgery with the Akreos MI60 microincision lens (Bausch & Lomb) is a safe and effective procedure.

Cataract surgery with the Akreos MI60 microincision lens (Bausch & Lomb) is a safe and effective procedure, according to Jorge Alio and co-workers from VISSUM Instituto Oftalmologica de Alicante, Spain and study groups in France, Germany, Italy and Sweden.

The study enrolled 98 eyes to be implanted with the Akreos lens using bimanual phaco with the Millenium system (Bausch & Lomb), a wound-assisted MI60 lens implantation and a 1.8 mm cartridge. Mean age of subjects was 70 years and the mean preoperative spherical equivalent was -0.53±2.93 D.

The corneal incision changed from a pre-implant value of 1.68±0.24 mm to a post-implant value of 1.82±0.16 mm, implying a wound stretch with implantation of 0.14±0.22 mm. Postoperative spherical equivalent was -0.05±0.90 D, while best corrected visual acuity (BCVA) improved from 0.42±0.25 to 0.04±0.18.

The research group believe that cataract surgery using the Akreos MI60 microincision lens produces excellent visual and refractive outcomes.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.